| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
7,019 |
5,115 |
$464K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,239 |
3,119 |
$81K |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
3,254 |
2,638 |
$51K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,818 |
1,551 |
$28K |
| 87631 |
|
1,137 |
1,008 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
799 |
768 |
$8K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
124 |
109 |
$6K |
| 87486 |
|
1,119 |
993 |
$4K |
| 87581 |
|
1,120 |
993 |
$4K |
| 87653 |
|
855 |
723 |
$4K |
| 87481 |
|
815 |
692 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
217 |
205 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
42 |
33 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
217 |
205 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
369 |
335 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
163 |
155 |
$1K |
| 87563 |
|
215 |
203 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
35 |
22 |
$975.17 |
| 87541 |
|
187 |
128 |
$912.00 |
| 87641 |
|
220 |
186 |
$840.35 |
| 87500 |
|
186 |
174 |
$812.28 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
110 |
108 |
$296.28 |
| 87181 |
|
28 |
28 |
$198.28 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
232 |
149 |
$88.11 |
| 81003 |
|
530 |
455 |
$82.86 |
| 87076 |
|
28 |
28 |
$46.31 |
| 87640 |
|
89 |
61 |
$43.86 |
| 81001 |
|
41 |
41 |
$24.11 |